Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shane Solomon Neibart, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jethwa KR, Neibart SS, Truty MJ, Jabbour SK, Hallemeier CL. Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rationale and Target Delineation for (Neo)Adjuvant Radiation Therapy. Pract Radiat Oncol. 2022 Nov-Dec; 12(6):e463-e473. PMID: 35718073.
    Citations:    Fields:    Translation:Humans
  2. Neibart SS, Mamidanna S, Chundury A, Sayan M, Alexander HR, August DA, Berim LD, Boland PM, Grandhi MS, Gulhati P, Hochster HS, Langan RC, Spencer KR, Kennedy TJ, Deek MP, Jabbour SK. Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy. J Gastrointest Oncol. 2021 Dec; 12(6):2557-2566. PMID: 35070387; PMCID: PMC8748032.
    Citations: 1     
  3. Piperdi H, Portal D, Neibart SS, Yue NJ, Jabbour SK, Reyhan M. Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field. Front Oncol. 2021; 11:770382. PMID: 34912715; PMCID: PMC8666420.
    Citations: 5     
  4. Neibart SS, Portal DE, Malhotra J, Jabbour SK, Roy JA, Strom BL. Validation of a claims-based algorithm for identifying non-infectious pneumonitis in patients diagnosed with lung cancer. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1624-1629. PMID: 34378828; PMCID: PMC8578340.
    Citations:    Fields:    Translation:Humans
  5. Neibart SS, Smith TA, Fang JH, Anderson T, Kulkarni A, Tsui J, Hudson SV, Peck GL, Hanna JS, Beer NL, Einstein MH. Assessment of Cervical Cancer Prevention and Treatment Infrastructure in Belize. JCO Glob Oncol. 2021 08; 7:1251-1259. PMID: 34351814; PMCID: PMC8389877.
    Citations:    Fields:    Translation:Humans
  6. Bradaschia-Correa V, Leclerc K, Josephson AM, Lee S, Palma L, Litwa HP, Neibart SS, Huo JC, Leucht P. Author Correction: Hox gene expression determines cell fate of adult periosteal stem/progenitor cells. Sci Rep. 2020 Feb 18; 10(1):3220. PMID: 32066822; PMCID: PMC7026393.
    Citations: 1     Fields:    
  7. Neibart SS, Manne SL, Jabbour SK. Quality of Life After Radiotherapy for Rectal and Anal Cancer. Curr Colorectal Cancer Rep. 2020 Feb; 16(1):1-10. PMID: 32632345; PMCID: PMC7336840.
    Citations: 1     
  8. Bradaschia-Correa V, Leclerc K, Josephson AM, Lee S, Palma L, Litwa HP, Neibart SS, Huo JC, Leucht P. Hox gene expression determines cell fate of adult periosteal stem/progenitor cells. Sci Rep. 2019 03 25; 9(1):5043. PMID: 30911091; PMCID: PMC6434021.
    Citations: 7     Fields:    Translation:AnimalsCells
  9. Josephson AM, Bradaschia-Correa V, Lee S, Leclerc K, Patel KS, Muinos Lopez E, Litwa HP, Neibart SS, Kadiyala M, Wong MZ, Mizrahi MM, Yim NL, Ramme AJ, Egol KA, Leucht P. Age-related inflammation triggers skeletal stem/progenitor cell dysfunction. Proc Natl Acad Sci U S A. 2019 04 02; 116(14):6995-7004. PMID: 30894483; PMCID: PMC6452701.
    Citations: 56     Fields:    Translation:HumansAnimalsCells
  10. Bravo D, Josephson AM, Bradaschia-Correa V, Wong MZ, Yim NL, Neibart SS, Lee SN, Huo J, Coughlin T, Mizrahi MM, Leucht P. Temporary inhibition of the plasminogen activator inhibits periosteal chondrogenesis and promotes periosteal osteogenesis during appendicular bone fracture healing. Bone. 2018 07; 112:97-106. PMID: 29680264; PMCID: PMC5970081.
    Citations: 3     Fields:    Translation:AnimalsCells
  11. Bradaschia-Correa V, Josephson AM, Mehta D, Mizrahi M, Neibart SS, Liu C, Kennedy OD, Castillo AB, Egol KA, Leucht P. The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice. J Bone Miner Res. 2017 04; 32(4):821-833. PMID: 27869327; PMCID: PMC5395314.
    Citations: 23     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Neibart's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (49)
Co-Authors (1)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.